Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

INTRODUCTION: This study assessed if concomitant use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or corticosteroids altered the response or safety outcomes to baricitinib in rheumatoid arthritis (RA) patients. METHODS: Patients with ≥ 6 swollen/tender joints and no pri...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251844/
https://www.ncbi.nlm.nih.gov/pubmed/30357613
http://dx.doi.org/10.1007/s40744-018-0128-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251844/
https://www.ncbi.nlm.nih.gov/pubmed/30357613
http://dx.doi.org/10.1007/s40744-018-0128-0

Ejemplares similares